| Variable . | Patients, n = 604 . |
|---|---|
| Age (years), median (range) | 73 (65–90) |
| Sex male, n (%) | 477 (79) |
| BMI (kg/m2), mean ± SD | 27.6 ± 13.0 |
| Smoker, n (%) | 107 (18) |
| Hypertension, n (%) | 441 (73) |
| Diabetes (%), n (%) | 120 (20) |
| Cerebrovascular events, n (%) | 63 (10) |
| Peripheral artery disease, n (%) | 92 (15) |
| Gastrointestinal disease, n (%) | 37 (6) |
| Atrial fibrillation, n (%) | 114 (19) |
| Myocardial infarction, n (%) | 151 (25) |
| PCI, n (%) | 84 (14) |
| Ejection fraction, n (%) | |
| ≥50 | 414 (69) |
| ≥31 | 129 (21) |
| ≤30 | 54 (9) |
| NYHA, n (%) | |
| I | 160 (26) |
| II | 266 (44) |
| III | 161 (27) |
| IV | 16 (3) |
| CCS, n (%) | |
| 0 | 204 (34) |
| I | 136 (23) |
| II | 146 (24) |
| III | 106 (18) |
| IV | 11 (2) |
| Impaired renal function (Cr above 110 μmol/l), n (%) | 76 (13) |
| Renal diseases, n (%) | 26 (4) |
| Creatinine (μmol/l), median (range) | 90 (47–1227) |
| eGFR, median (range) | 69 (6–96) |
| EuroSCORE II, median (range) | 2 (0.6–39.0) |
| STS score, median (range) | 1.3 (0.1–17.2) |
| CAF score, median (range) | 7 (1–30) |
| FORECAST, median (range) | 4 (1–14) |
| Admission condition, n (%) | |
| Elective | 496 (82) |
| Subacute | 108 (18) |
| Type of surgery, n (%) | |
| CABG | 337 (56) |
| Valve | 175 (29) |
| Combined | 92 (15) |
| Variable . | Patients, n = 604 . |
|---|---|
| Age (years), median (range) | 73 (65–90) |
| Sex male, n (%) | 477 (79) |
| BMI (kg/m2), mean ± SD | 27.6 ± 13.0 |
| Smoker, n (%) | 107 (18) |
| Hypertension, n (%) | 441 (73) |
| Diabetes (%), n (%) | 120 (20) |
| Cerebrovascular events, n (%) | 63 (10) |
| Peripheral artery disease, n (%) | 92 (15) |
| Gastrointestinal disease, n (%) | 37 (6) |
| Atrial fibrillation, n (%) | 114 (19) |
| Myocardial infarction, n (%) | 151 (25) |
| PCI, n (%) | 84 (14) |
| Ejection fraction, n (%) | |
| ≥50 | 414 (69) |
| ≥31 | 129 (21) |
| ≤30 | 54 (9) |
| NYHA, n (%) | |
| I | 160 (26) |
| II | 266 (44) |
| III | 161 (27) |
| IV | 16 (3) |
| CCS, n (%) | |
| 0 | 204 (34) |
| I | 136 (23) |
| II | 146 (24) |
| III | 106 (18) |
| IV | 11 (2) |
| Impaired renal function (Cr above 110 μmol/l), n (%) | 76 (13) |
| Renal diseases, n (%) | 26 (4) |
| Creatinine (μmol/l), median (range) | 90 (47–1227) |
| eGFR, median (range) | 69 (6–96) |
| EuroSCORE II, median (range) | 2 (0.6–39.0) |
| STS score, median (range) | 1.3 (0.1–17.2) |
| CAF score, median (range) | 7 (1–30) |
| FORECAST, median (range) | 4 (1–14) |
| Admission condition, n (%) | |
| Elective | 496 (82) |
| Subacute | 108 (18) |
| Type of surgery, n (%) | |
| CABG | 337 (56) |
| Valve | 175 (29) |
| Combined | 92 (15) |
CABG: coronary artery bypass graft; CAF: comprehensive assessment of frailty; CCS: Canadian cardiovascular society; EuroSCORE: European System for Cardiac Operative Risk Evaluation; FORECAST: frailty predicts death one year after elective cardiac surgery test; NYHA: New York Heart Association; PCI:Percutaneous coronary intervention; SD: standard deviation; STS: Society of Thoracic Surgeons.
| Variable . | Patients, n = 604 . |
|---|---|
| Age (years), median (range) | 73 (65–90) |
| Sex male, n (%) | 477 (79) |
| BMI (kg/m2), mean ± SD | 27.6 ± 13.0 |
| Smoker, n (%) | 107 (18) |
| Hypertension, n (%) | 441 (73) |
| Diabetes (%), n (%) | 120 (20) |
| Cerebrovascular events, n (%) | 63 (10) |
| Peripheral artery disease, n (%) | 92 (15) |
| Gastrointestinal disease, n (%) | 37 (6) |
| Atrial fibrillation, n (%) | 114 (19) |
| Myocardial infarction, n (%) | 151 (25) |
| PCI, n (%) | 84 (14) |
| Ejection fraction, n (%) | |
| ≥50 | 414 (69) |
| ≥31 | 129 (21) |
| ≤30 | 54 (9) |
| NYHA, n (%) | |
| I | 160 (26) |
| II | 266 (44) |
| III | 161 (27) |
| IV | 16 (3) |
| CCS, n (%) | |
| 0 | 204 (34) |
| I | 136 (23) |
| II | 146 (24) |
| III | 106 (18) |
| IV | 11 (2) |
| Impaired renal function (Cr above 110 μmol/l), n (%) | 76 (13) |
| Renal diseases, n (%) | 26 (4) |
| Creatinine (μmol/l), median (range) | 90 (47–1227) |
| eGFR, median (range) | 69 (6–96) |
| EuroSCORE II, median (range) | 2 (0.6–39.0) |
| STS score, median (range) | 1.3 (0.1–17.2) |
| CAF score, median (range) | 7 (1–30) |
| FORECAST, median (range) | 4 (1–14) |
| Admission condition, n (%) | |
| Elective | 496 (82) |
| Subacute | 108 (18) |
| Type of surgery, n (%) | |
| CABG | 337 (56) |
| Valve | 175 (29) |
| Combined | 92 (15) |
| Variable . | Patients, n = 604 . |
|---|---|
| Age (years), median (range) | 73 (65–90) |
| Sex male, n (%) | 477 (79) |
| BMI (kg/m2), mean ± SD | 27.6 ± 13.0 |
| Smoker, n (%) | 107 (18) |
| Hypertension, n (%) | 441 (73) |
| Diabetes (%), n (%) | 120 (20) |
| Cerebrovascular events, n (%) | 63 (10) |
| Peripheral artery disease, n (%) | 92 (15) |
| Gastrointestinal disease, n (%) | 37 (6) |
| Atrial fibrillation, n (%) | 114 (19) |
| Myocardial infarction, n (%) | 151 (25) |
| PCI, n (%) | 84 (14) |
| Ejection fraction, n (%) | |
| ≥50 | 414 (69) |
| ≥31 | 129 (21) |
| ≤30 | 54 (9) |
| NYHA, n (%) | |
| I | 160 (26) |
| II | 266 (44) |
| III | 161 (27) |
| IV | 16 (3) |
| CCS, n (%) | |
| 0 | 204 (34) |
| I | 136 (23) |
| II | 146 (24) |
| III | 106 (18) |
| IV | 11 (2) |
| Impaired renal function (Cr above 110 μmol/l), n (%) | 76 (13) |
| Renal diseases, n (%) | 26 (4) |
| Creatinine (μmol/l), median (range) | 90 (47–1227) |
| eGFR, median (range) | 69 (6–96) |
| EuroSCORE II, median (range) | 2 (0.6–39.0) |
| STS score, median (range) | 1.3 (0.1–17.2) |
| CAF score, median (range) | 7 (1–30) |
| FORECAST, median (range) | 4 (1–14) |
| Admission condition, n (%) | |
| Elective | 496 (82) |
| Subacute | 108 (18) |
| Type of surgery, n (%) | |
| CABG | 337 (56) |
| Valve | 175 (29) |
| Combined | 92 (15) |
CABG: coronary artery bypass graft; CAF: comprehensive assessment of frailty; CCS: Canadian cardiovascular society; EuroSCORE: European System for Cardiac Operative Risk Evaluation; FORECAST: frailty predicts death one year after elective cardiac surgery test; NYHA: New York Heart Association; PCI:Percutaneous coronary intervention; SD: standard deviation; STS: Society of Thoracic Surgeons.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
